Drug Shows Promise for Subset of Non-Small Cell Lung Cancer
NYU Langone medical oncologist Dr. Vamsidhar Velcheti discusses a promising treatment for people with a subset of non-small cell lung cancer.
EPA5 Attending Supervision Tool
... and compassionate communication with the patient, ordering physician, and ancillary staff and document in medical ...
Gynecologic Cancer & COVID-19
NYU Langone gynecologic oncologist Dr. Bhavana Pothuri discusses the research on COVID-19 and people with gynecologic cancer.
Health Systems on Long Island Expand Cancer Care Programs
NYU Langone’s Perlmutter Cancer Center and other regional healthcare systems on Long Island are enhancing local access to cancer care.
How NYU Langone Is Preparing for a Second Wave of COVID-19
Chief medical officer and patient safety officer Dr. Fritz François shares NYU Langone’s preparations for a second wave of COVID-19.
Immunotherapy Clinical Trial Gives Hope for Rare Skin Cancer
A participant in an immunotherapy clinical trial offered by NYU Langone’s Perlmutter Cancer Center shares her experience.
Inside Medicine - May 18, 2020
... and the medical students is a wonderful and heartwarming collaboration,” says Dr. Tanner. “The students ... included medical students Allyson Alfonso, Gwendolyn Cody, Mark Cort, Allison Horan, Keshav Mangalick ...
New Drug Atezolizumab Fights Advanced Bladder Cancer
A study led by a researcher at NYU Langone shows that the new drug atezolizumab is highly effective against advanced bladder cancer.
NYU Langone Tops Stroke, Critical & Pulmonary Care in State
NYU Langone is the state’s top-ranked hospital in critical care, pulmonary care, and stroke care in Healthgrades’ 2022 rankings.
Ways to Reduce Your Risk of Prostate Cancer
NYU Langone medical oncologist Dr. David Wise shares lifestyle habits men can incorporate to significantly reduce their risk of prostate cancer.